Klobeskin ointment it is shown for short-term treatment:

• Psoriasis (except for widespread blyashechny psoriasis);
• Dermatosis, difficult responding to treatment;
Red flat depriving of
• ;
• Diskoidny lupus erythematosus.

Structure

Active ingredient: clobetasol;

1 g of drug;

Excipients: propylene glycol, sorbitan sesquioleate, paraffin white soft.

Contraindication

Hypersensitivity to any components of drug. Uncured infections of skin, a rozatse, ordinary eels, an itching without inflammation, a perianal and genital itching, perioral dermatitis. Drug is not intended for treatment of a dermatosis at children aged till 1 year, including dermatitis and diaper pour.

Ointment especially is suitable

for treatment of the damages of skin which are followed by its dryness, likhenifikatsiyeyu or the peeling phenomena.

it is soft to p to apply Ointment a thin layer, covering all affected areas of skin, 1 or 2 times a day before emergence of improvement of clinical manifestations (on condition of the good response to treatment the improvement is reached for several days), then to reduce the frequency of use or to replace medicament with less powerful. After each putting ointment to wait some time before its full absorption before applying emollient.

Feature of use

Pregnant

Only if the expected advantage for mother exceeds risk for a fruit.

Drug is contraindicated to

for treatment of a dermatosis, including dermatitis at children till 1 year.

Drivers

does not influence.

Overdose

Symptoms. At usual use klobetazol it can be absorbed in the quantities sufficient for emergence of system effect. Probability of emergence of acute overdose is very insignificant, however in case of chronic overdose or the wrong use there can be signs of a hypercorticoidism.

Treatment. In case of overdose, medicament should be cancelled gradually by reduction of frequency of putting ointment or substitution it on less powerful GKS considering risk of emergence of GKS of insufficiency.

it agrees a clinical condition of the patient or according to national recommendations about treatment of poisonings (in the presence).

Side effects

from the immune system: local hypersensitivity.

from skin and hypodermic fabrics: an itching, feeling local skin burnings/pains, a local atrophy of skin, atrophic strips on telangiectasia skin thinning of skin, wrinkling of skin, drying of skin, pigmentation change, a hypertrichosis, aggravation of the main symptoms, allergic contact dermatitis / dermatitis, a pustulous form of psoriasis, an erythema, rash, urticaria, an acne.

Interaction

Was shown that combined use with medicaments which can inhibit CYP3A4 (for example with ritonaviry, itrakonazoly) slows down metabolism of corticosteroids, can cause system effect.

to Store

in original packing at a temperature not above 25 °C.

to Store

out of children's reach.

Expiration date - 2 years.